EW Edwards Lifesciences Corp

NYSE edwards.com


$ 82.83 $ -1.31 (-1.56 %)    

Wednesday, 05-Nov-2025 15:59:57 EST
QQQ $ 622.38 $ 4.94 (0.8 %)
DIA $ 473.04 $ 2.23 (0.47 %)
SPY $ 677.28 $ 2.47 (0.37 %)
TLT $ 89.01 $ -0.57 (-0.64 %)
GLD $ 365.20 $ 0.10 (0.03 %)
$ 82.84
$ 84.05
$ 82.00 x 1
$ 84.20 x 100
$ 82.54 - $ 84.54
$ 64.89 - $ 87.09
3,633,093
na
48.07B
$ 1.02
$ 35.14
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-28-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 04-29-2024 03-31-2024 10-Q
8 02-12-2024 12-31-2023 10-K
9 10-27-2023 09-30-2023 10-Q
10 07-28-2023 06-30-2023 10-Q
11 04-28-2023 03-31-2023 10-Q
12 02-13-2023 12-31-2022 10-K
13 10-28-2022 09-30-2022 10-Q
14 07-29-2022 06-30-2022 10-Q
15 04-28-2022 03-31-2022 10-Q
16 02-14-2022 12-31-2021 10-K
17 10-29-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-28-2021 03-31-2021 10-Q
20 02-12-2021 12-31-2020 10-K
21 10-26-2020 09-30-2020 10-Q
22 07-27-2020 06-30-2020 10-Q
23 04-28-2020 03-31-2020 10-Q
24 02-14-2020 12-31-2019 10-K
25 10-25-2019 09-30-2019 10-Q
26 07-26-2019 06-30-2019 10-Q
27 04-26-2019 03-31-2019 10-Q
28 02-15-2019 12-31-2018 10-K
29 10-26-2018 09-30-2018 10-Q
30 07-27-2018 06-30-2018 10-Q
31 04-27-2018 03-31-2018 10-Q
32 02-16-2018 12-31-2017 10-K
33 10-27-2017 09-30-2017 10-Q
34 07-28-2017 06-30-2017 10-Q
35 04-28-2017 03-31-2017 10-Q
36 02-17-2017 12-31-2016 10-K
37 10-28-2016 09-30-2016 10-Q
38 07-29-2016 06-30-2016 10-Q
39 04-29-2016 03-31-2016 10-Q
40 02-19-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-hold-on-edwards-lifesciences-raises-price-target-to-90

Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target ...

 canaccord-genuity-maintains-hold-on-edwards-lifesciences-raises-price-target-to-84

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target ...

 barclays-maintains-overweight-on-edwards-lifesciences-raises-price-target-to-99

Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $95...

 citigroup-maintains-buy-on-edwards-lifesciences-raises-price-target-to-96

Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $95 to...

 jp-morgan-maintains-neutral-on-edwards-lifesciences-raises-price-target-to-90

JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $85...

 goldman-sachs-maintains-buy-on-edwards-lifesciences-raises-price-target-to-104

Goldman Sachs analyst David Roman maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $94 t...

 nasdaq-100-rebounds-amazon-jumps-10-on-strong-earnings-whats-moving-markets-friday

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap gi...

 piper-sandler-reiterates-overweight-on-edwards-lifesciences-raises-price-target-to-95

Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target fr...

 rbc-capital-maintains-outperform-on-edwards-lifesciences-raises-price-target-to-95

RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from...

 stifel-maintains-buy-on-edwards-lifesciences-raises-price-target-to-95

Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $85 to $95.

 evercore-isi-group-maintains-outperform-on-edwards-lifesciences-raises-price-target-to-92

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price targe...

 mizuho-maintains-outperform-on-edwards-lifesciences-raises-price-target-to-100

Mizuho analyst Anthony Petrone maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $...

 edwards-lifesciences-raises-fy2025-sales-guidance-from-5900b-6100b-to-5929b-6100b-vs-5982b-est

OutlookEdwards is increasing its full-year total company sales growth guidance to the high end of 9% to 10%. In addition, the c...

 edwards-lifesciences-raises-fy2025-adj-eps-guidance-from-245-255-to-256-262-vs-251-est

OutlookEdwards is increasing its full-year total company sales growth guidance to the high end of 9% to 10%. In addition, the c...

 edwards-lifesciences-sees-q4-adj-eps-058-064-vs-061-est-sees-sales-1510b-1590b-vs-1542b-est

OutlookEdwards is increasing its full-year total company sales growth guidance to the high end of 9% to 10%. In addition, the c...

 edwards-lifesciences-cfo-scott-ullem-to-step-down-by-mid-2026

Edwards Lifesciences (NYSE: EW) today announced that Scott Ullem, the company's chief financial officer, has decided to tra...

 edwards-lifesciences-q3-adj-eps-067-beats-059-estimate-sales-1553b-beat-1495b-estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.5...

 meta-tumbles-10-google-marks-historic-rally-whats-moving-markets-thursday

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION